Keyphrases
Aldosterone
43%
Aldosterone Blockade
12%
Allopurinol
33%
Angiotensin II (Ang II)
46%
Angiotensin-converting Enzyme
14%
Angiotensin-converting Enzyme Inhibitor (ACEi)
39%
Atrial Natriuretic Factor
23%
Atrial Natriuretic Peptide
24%
B-type Natriuretic Peptide
33%
Beta-blockers
11%
Blood Pressure
31%
Brain Natriuretic Peptide
18%
Captopril
15%
Cardiac Magnetic Resonance Imaging (cMRI)
11%
Cardiovascular Disease
13%
Cardiovascular Risk
11%
Chronic Heart Failure
53%
Confidence Interval
13%
Coronary Artery Disease
13%
Diuretics
11%
Echocardiography
13%
Endothelial Dysfunction
14%
Endothelial Function
20%
Heart Failure
48%
Heart Failure Patients
22%
Heart Rate
13%
High Dose
14%
Hypertension
15%
Left Ventricular Dysfunction
11%
Left Ventricular Hypertrophy
30%
Left Ventricular Mass
18%
Left Ventricular Systolic Dysfunction
18%
Myocardial Infarction
12%
Natriuretic Peptides
12%
Noradrenaline
12%
Older People
16%
Patients with Chronic Heart Failure
17%
Patients with Heart Failure
18%
Physical Function
11%
Placebo
53%
QT Dispersion
16%
Randomized Controlled Trial
28%
Randomized Placebo-controlled Trial
11%
Renin-angiotensin-aldosterone System
12%
Sarcopenia
13%
Spironolactone
30%
Systolic Blood Pressure
12%
Type 2 Diabetes Mellitus (T2DM)
15%
Type 2 Diabetic Patients
11%
Whole-body
11%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylcholine
6%
Acute Heart Infarction
9%
Aldosterone
40%
Allopurinol
31%
Angiotensin
17%
Angiotensin I
7%
Angiotensin II
35%
Angiotensin Receptor Antagonist
7%
Atrial Natriuretic Factor
28%
Beta Adrenergic Receptor Blocking Agent
7%
Brain Natriuretic Peptide
33%
Captopril
15%
Cardiovascular Disease
12%
Cardiovascular Risk
6%
Cerebrovascular Accident
6%
Ciclosporin
6%
Cohort Study
6%
Congestive Heart Failure
100%
Coronary Artery Disease
13%
Diabetes Mellitus
14%
Dipeptidyl Carboxypeptidase
21%
Dipeptidyl Carboxypeptidase Inhibitor
37%
Diuretics
7%
Enalapril
8%
Endothelial Dysfunction
13%
Enzyme Inhibition
6%
Epinephrine
11%
Furosemide
8%
Heart Infarction
13%
Heart Left Ventricle Failure
7%
Heart Left Ventricle Hypertrophy
18%
Hypokalemia
6%
Ischemic Heart Disease
6%
Isotopes of Potassium
10%
Left Ventricular Systolic Dysfunction
7%
Losartan
5%
Metformin
5%
Natriuretic Factor
12%
Nitric Oxide
8%
Non Insulin Dependent Diabetes Mellitus
16%
Noradrenalin
20%
Normal Human
11%
Placebo
53%
Randomized Controlled Trial
16%
Renin
24%
Salbutamol
6%
Sarcopenia
5%
Spironolactone
25%
Urate
6%
Vitamin D
8%
Medicine and Dentistry
ACE Inhibitor
25%
Aldosterone
30%
Allopurinol
15%
Angiotensin II
19%
Apoplexy
11%
Arterial Stiffness
10%
Atrial Natriuretic Factor
15%
Blood Pressure
23%
Brain Natriuretic Peptide
40%
Cardiac Magnetic Resonance Imaging
10%
Cardiovascular Disease
15%
Cardiovascular Effect
6%
Cardiovascular Risk
8%
Cardiovascular System
17%
Chronic Obstructive Pulmonary Disease
10%
Congestive Heart Failure
80%
Coronary Artery Disease
14%
Cyclosporine
8%
Diabetes
6%
Diabetes Mellitus
11%
Dipeptidyl Carboxypeptidase
7%
Diuretics
7%
Echocardiography
13%
Electrocardiogram
9%
Endothelial Dysfunction
8%
Endothelial Function
15%
Heart Death
8%
Infusion
7%
Ischemic Heart Disease
7%
Left Ventricular Hypertrophy
22%
Left Ventricular Systolic Dysfunction
15%
Maturity Onset Diabetes of the Young
9%
Meta-Analysis
6%
Myocardial Infarction
7%
Natriuretic Factor
9%
Noradrenalin
7%
Patient with Type 2 Diabetes
6%
Perindopril
9%
Physical Performance
8%
Placebo
37%
Prevalence
7%
QT Dispersion
8%
Quality of Life
7%
Randomized Controlled Trial
26%
Sarcopenia
10%
Spironolactone
12%
Supplementation
7%
Systolic Blood Pressure
7%
Vitamin D
9%
Volunteer
8%